Jun. 22 at 2:24 AM
🚨
$SLS WEEK OF TRUTH 🚨
Let’s review the setup:
⏳ REGAL still hasn’t reached Event #80
📈 Trial continues far beyond expectations
♾️ FDA approved unlimited dosing
💰 ~
$135M cash removes financing concerns
🔥 Shorts remain trapped paying elevated borrow fees
Now add this:
Abbvie is reportedly spending ~
$11B on oncology.
Big Pharma isn’t pulling back… they’re writing bigger checks.
So if AbbVie is busy, who’s next?
👀
$MRK
👀
$PFE
👀
$RHHBY
👀
$BMY
The longer REGAL runs, the harder it becomes to explain using the bear thesis.
At some point the conversation shifts from:
“Will GPS work?”
To:
“Who wants GPS first?”
The clock is ticking. 🚀🔥
#AML #Cancer #Biotech #MA
